Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -35.27% is 29% below its 5-year average of -27.28%, around the middle of its 5-year range (-59.68%–-11.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 17.92% above its 12-month average of -42.96%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -35.27%.
RETURN ON INVESTED CAPITAL (ROIC)
-35.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-42.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-33.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-30.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.92%
CURRENT VS 3Y AVG
-5.75%
CURRENT VS 5Y AVG
-29.29%
CURRENT VS 10Y AVG
-14.25%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+1.10%
vs the sector median at left
Xenon Pharmaceuticals Inc.
Market Cap
$3.54B
Return on Invested Capital (ROIC)
-35.27%
TTM Avg
-42.96%
3Y Avg
-33.35%
5Y Avg
-27.28%
Market Cap
$3.52B
Return on Invested Capital (ROIC)
-1.07%
TTM Avg
-9.16%
3Y Avg
-22.10%
5Y Avg
-20.63%
Market Cap
$3.56B
Return on Invested Capital (ROIC)
6.72%
TTM Avg
3.30%
3Y Avg
-1.32%
5Y Avg
-3.44%
Market Cap
$3.57B
Return on Invested Capital (ROIC)
-12.91%
TTM Avg
-40.91%
3Y Avg
-35.75%
5Y Avg
-31.17%
Market Cap
$3.48B
Return on Invested Capital (ROIC)
-17.68%
TTM Avg
-22.74%
3Y Avg
-21.16%
5Y Avg
-18.86%
Market Cap
$3.47B
Return on Invested Capital (ROIC)
-28.15%
TTM Avg
-46.92%
3Y Avg
-38.64%
5Y Avg
-44.96%
Market Cap
$3.44B
Return on Invested Capital (ROIC)
-79.40%
TTM Avg
-65.84%
3Y Avg
-73.62%
5Y Avg
-96.54%
Market Cap
$3.64B
Return on Invested Capital (ROIC)
-69.75%
TTM Avg
-63.60%
3Y Avg
-55.78%
5Y Avg
-83.39%
Market Cap
$3.38B
Return on Invested Capital (ROIC)
6.25%
TTM Avg
16.80%
3Y Avg
-7.33%
5Y Avg
-16.60%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | $3.54B | -35.27% | -42.96% | -33.35% | -27.28% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -1.07% | -9.16% | -22.10% | -20.63% |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 6.72% | 3.30% | -1.32% | -3.44% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | -12.91% | -40.91% | -35.75% | -31.17% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -17.68% | -22.74% | -21.16% | -18.86% |
| Celcuity Inc. (CELC)vs › | $3.47B | -28.15% | -46.92% | -38.64% | -44.96% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -79.40% | -65.84% | -73.62% | -96.54% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | -69.75% | -63.60% | -55.78% | -83.39% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 6.25% | 16.80% | -7.33% | -16.60% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | -409.85% | -257.76% | -257.76% | -257.76% |
ROIC
-35.3%
ROE
-32.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -35.27% |
| 2026-03-31 | -30.64% |
| 2025-12-31 | -39.63% |
| 2025-09-30 | -59.68% |
| 2025-06-30 | -49.61% |
| 2025-03-31 | -41.19% |
| 2024-12-31 | -36.63% |
| 2024-09-30 | -31.69% |
| 2024-06-30 | -27.85% |
| 2024-03-31 | -24.98% |
| 2023-12-31 | -22.83% |
| 2023-09-30 | -31.51% |
| 2023-06-30 | -28.34% |
| 2023-03-31 | -23.06% |
| 2022-12-31 | -17.66% |
| 2022-09-30 | -14.55% |
| 2022-06-30 | -11.10% |
| 2022-03-31 | -14.60% |
| 2021-12-31 | -14.16% |
| 2021-09-30 | -26.67% |
| 2021-06-30 | -23.55% |
| 2021-03-31 | -14.09% |
| 2020-12-31 | -17.95% |
| 2020-09-30 | -16.45% |
| 2020-06-30 | -15.41% |
| 2020-03-31 | -19.15% |
| 2019-12-31 | -39.30% |
| 2019-09-30 | -43.66% |
| 2019-06-30 | -45.51% |
| 2019-03-31 | -38.79% |
| 2018-12-31 | -32.13% |
| 2018-09-30 | -29.86% |
| 2018-06-30 | -51.49% |
| 2018-03-31 | -91.61% |
| 2017-12-31 | -76.22% |
| 2017-09-30 | -69.25% |
| 2017-06-30 | -56.83% |
| 2017-03-31 | -47.46% |
| 2016-12-31 | -38.79% |
| 2016-09-30 | -31.64% |
| 2016-06-30 | -29.28% |
| 2016-03-31 | -15.24% |
| 2015-12-31 | -7.24% |
| 2015-09-30 | -2.77% |
| 2015-06-30 | 7.03% |
| 2015-03-31 | 7.61% |
| 2014-12-31 | 15.19% |
| 2014-09-30 | 34.61% |
| 2014-06-30 | 32.63% |
| 2013-12-31 | 19.73% |
| 2013-06-30 | -2.88% |
